Abstract
Ribosomal RNA modifications are important in optimizing ribosome function. Sugar 2′-O-methylation performed by fibrillarin-associated box C/D antisense guide snoRNAs impacts all steps of translation, playing a role in disease etiology (cancer). As it renders adjacent phosphodiester bonds resistant to alkaline treatment, 2′-O-methylation can be monitored qualitatively and quantitatively by applying next-generation sequencing to fragments of randomly cleaved RNA. We remapped all sites of 2′-O-methylation in human rRNAs in two isogenic diploid cell lines, one producing and one not producing the antitumor protein p53. We identified sites naturally modified only partially (confirming the existence in cells of compositionally distinct ribosomes with potentially specialized functions) and sites whose 2′-O-methylation is sensitive to p53. We mapped sites particularly vulnerable to a reduced level of the methyltransferase fibrillarin. The remarkable fact that these are largely sites of natural hypomodification provides initial insights into the mechanism of partial RNA modification. Sites where methylation appeared vulnerable lie peripherally on the 3-D structure of the ribosomal subunits, whereas the numerous modifications present at the core of the subunits, where the functional centers lie, appeared robustly made. We suggest that vulnerable sites of 2′-O-methylation are highly likely to undergo specific regulation during normal and pathological processes.
Highlights
Ribosomes are essential nanomachines which, in all living cells, convert the information encoded in messenger RNAs into proteins
For systematic mapping of 2′-O-methylation sites on human ribosomal RNAs, total RNA was extracted from HCT116 cells and subjected to RiboMethSeq, a deep-sequencing-based strategy relying on differential sensitivity of methylated residues to alkaline treatment[15]
Total RNA was fragmented by mild alkaline treatment, and the cleaved RNA fragments were used to generate sequencing libraries which were processed by HiSeq 100015
Summary
Ribosomes are essential nanomachines which, in all living cells, convert the information encoded in messenger RNAs into proteins. Recent research has revealed the existence of highly specific ribosomal diseases and of specialized ribosomes that might have distinct translational capacities[5]. RRNA modifications appear tightly connected to important biological processes such as cell differentiation[24] and embryonic development[25], and to severe disease, in particular cancer[26, 27]. Deep-sequencing-based strategies have been developed to map RNA modifications at the transcriptome-wide level. These strategies rely on the ability of RNA modifications to be detected by antibodies, to promote specific reverse transcriptase ‘drop off ’, to confer specific resistance to RNase digestion, or to induce specific cleavage of the RNA chain when subjected to particular chemical treatments (reviewed in refs 28–30)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.